Durvalumab vs Esomeprazole

Durvalumab vs Esomeprazole: Overview

This comparison examines the pharmacological differences between Durvalumab and Esomeprazole.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Esomeprazole: S-isomer of omeprazole; proton pump inhibitor irreversibly blocking gastric H+/K+-ATPase.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Esomeprazole — 1-1.5 hours.

Chemical Properties

Molecular Formula: Esomeprazole — C17H19N3O3S.

Molecular Weight: Esomeprazole — 345.4170 g/mol.

Type: Durvalumab — Antibody; Esomeprazole — Small molecule.